Heat Shock Protein-Based Therapies

<p>Contributors.- Preface.- 1 HSP27 as a Therapeutic Target of Novel Inhibitors and Dietary Phytochemicals in Cancer.- 2 Heat Shock Protein 27 (HSP27, HSPB1) is Up-Regulated by Targeted Agents and Confers Resistance to Both Targeted Drugs and Chemotherapeutics.- 3 Heat Shock Proteins and Cancer: Plant Based Therapy.- 4 Chaperonotherapy for Alzheimer’s Disease: Focusing on HSP60.- 5 Secreted and Circulating Cell Stress Proteins in the Periodontal Diseases.- 6 The Role of Heat Shock Protein 70 in Infection and Immunity.- 7 Potential Cytoprotective Effects of Heat Shock Proteins to Skeletal Muscle.- 8 Heat Shock Proteins in Triple-Negative Breast Cancer (TNBC) Treatment.- 9 Heat Shock Proteins in Multiple Sclerosis Pathogenesis: Friend or Foe?.- 10 New Indications for HSP90 and HSP70 Inhibitors as Antiviral Drugs.- 11 Potential Applications of Nanoparticles for Hyperthermia.- 12 Gene Therapy Against HSP90: Glucocorticoid Receptor-Assisted Cancer Treatment.- 13 Potential of HSP90 Inhibitors to Treat Neurofibromatosis-Related Tumors.- 14 Role of Heat Shock Protein 90 in the Cause of Various Diseases: A Potential Therapeutic Target.- 15 HSP90 Inhibitor-Based Strategies for Cancer Therapy: Advancing Toward Clinical Impact.- 16 Molecular Survival Strategies of Organisms: HSP and Small Molecules for Diagnostics and Drug Development.-17 Targeting Heat Shock Proteins in Colorectal Cancer.- Index.</p>